Tirzepatide and Nexplanon: correcting the most common assumption

Nexplanon is a subdermal implant that releases etonogestrel directly into the bloodstream — it bypasses the digestive system entirely, so slowed gastric emptying does not reduce its contraceptive effect.
The MHRA's advice about adding a non-oral contraceptive method during tirzepatide applies specifically to women taking the oral contraceptive pill, not to implant or injection users.
Despite this reassurance, any changes to your contraceptive needs while on tirzepatide (including planning a pregnancy) should be discussed with your prescriber or GP.
Tirzepatide is not recommended during pregnancy or breastfeeding; women who wish to conceive should stop treatment and observe a wash-out period as advised by their prescriber.

If you have a Nexplanon implant and are considering tirzepatide for weight management, the most reassuring thing to know is this: unlike oral contraceptives, the implant is not absorbed through the gut, so tirzepatide's effect on gastric emptying does not interfere with how it works. That said, the full picture is worth understanding before you start treatment, because tirzepatide is a prescription-only medicine that requires a clinical assessment to confirm it is right for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The full picture on tirzepatide, Nexplanon, and what actually needs attention

The misconception: tirzepatide disrupts hormonal contraception across the board

A concern that comes up frequently (and understandably) is whether starting tirzepatide will interfere with a hormonal contraceptive implant such as Nexplanon. The worry has a reasonable basis: tirzepatide slows the rate at which the stomach empties, and that change in gastric motility can reduce how well orally-taken medicines are absorbed into the body. For women on the combined oral contraceptive pill or progestogen-only pill, this is clinically relevant.

Nexplanon works differently. It is a small flexible rod inserted just under the skin of the upper arm, and it releases the hormone etonogestrel directly into the surrounding tissue and then into the bloodstream. There is no oral absorption step, no journey through the stomach, and therefore no mechanism by which slowed gastric emptying could diminish its effectiveness. The MHRA's specific guidance on oral contraceptives and tirzepatide simply does not apply to implant users in the same way.

NHS England's guidance on weight-management injections confirms this distinction: it is women using the oral contraceptive pill who are advised to add a non-oral method for the first four weeks of tirzepatide treatment and for four weeks after each dose increase. If you rely on Nexplanon, that particular precaution is not directed at you. It is worth reading the guidance yourself — NHS England's page on weight-management injections sets this out clearly and is updated as clinical thinking evolves.

What tirzepatide actually is, and why oral absorption matters for some medicines but not all

Tirzepatide is a once-weekly injection sold in the UK under the brand name Mounjaro. It activates two gut-hormone receptors, GIP and GLP-1, which work together to reduce appetite, slow stomach emptying, and support weight loss. You can read more about how it works on the tirzepatide overview page.

The slowing of gastric emptying is useful therapeutically, it is one reason people feel fuller for longer. But it creates a relevant question for any medicine or supplement that relies on consistent oral absorption. Oral contraceptives are absorbed in the gut; if the gut takes longer to process them, peak hormone levels can shift. That is the root of the pill-specific caution.

Nexplanon, by contrast, delivers etonogestrel at a steady, predictable rate through the implant itself. The gastrointestinal system plays no part. A useful one-minute check: look at your contraceptive method and confirm whether it involves swallowing something daily. If it does not (implant, injection, coil, patch) the gastric-emptying concern does not apply to its mechanism of action. That is not a substitute for a clinical conversation, but it helps frame the right question to ask.

For anyone wanting to understand the cost implications of starting treatment, our Mounjaro cost page explains how private pricing works and what a legitimate service includes.

Pregnancy planning, the wash-out period, and when to pause treatment

Tirzepatide is not recommended for use during pregnancy or breastfeeding, or for people actively trying to conceive. This applies regardless of which contraceptive method someone uses. If your circumstances change (if you and your partner decide to start trying) that is the moment to contact your prescriber before stopping treatment unilaterally, not after.

The MHRA advises using effective contraception throughout treatment and for a period after stopping. The exact wash-out period is specified in the Patient Information Leaflet and should be confirmed with your prescriber at the time, since it can depend on how long you have been on treatment and the dose you were taking. Our tirzepatide treatment plan page covers what clinical oversight looks like over the course of treatment.

One area sometimes overlooked is how body-composition changes from significant weight loss can affect fertility, cycles may change as weight reduces, and assumptions about fertility should be revisited with a GP if relevant. This is not a concern unique to tirzepatide; it applies to meaningful weight loss by any route. A prescriber who reviews you at each stage of treatment is placed to flag it. At nume, every repeat order is looked at by a GPhC-registered prescriber, not reviewed automatically.

Other situations worth raising with your prescriber before starting

Nexplanon compatibility aside, the broader safety profile of tirzepatide is worth knowing. The most common side effects are gastrointestinal: nausea tends to be most noticeable after a new pen is started or a dose steps up, and it typically eases within a couple of weeks. Constipation, loose stools, and reflux are also reported. The NHS tirzepatide page lists these in plain language alongside the symptoms that warrant prompt medical attention.

More serious but less common concerns include pancreatitis (severe stomach pain that spreads to the back) and gallbladder problems. These do not interact specifically with Nexplanon, but they are part of the full picture any prescriber will cover during your consultation. Anyone with a personal or close family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 will not be suitable for tirzepatide, and those conditions are screened during assessment. If you have a neurological condition such as multiple sclerosis and want to understand whether treatment is appropriate, our tirzepatide and MS page addresses that specific question in detail.

If you are also using HRT alongside your implant, there is a separate but related question about how tirzepatide may affect HRT absorption, our HRT and tirzepatide page covers that in detail. For a broader view of all treatment options available through an online assessment, the weight-loss treatments page is the right starting point. If you have questions before you begin, our team is reachable via the contact page.

Tirzepatide is a prescription-only medicine. A prescriber assesses your full medical picture, including your contraceptive method, before any treatment is approved. Check your eligibility with a free consultation, and if you would like a full summary of the evidence on how tirzepatide supports weight loss, our tirzepatide evidence page brings the clinical data together in one place.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions